Publicly Traded Hospice Companies Poised for Deals

The nation’s publicly traded hospice companies are primed for more acquisitions after a 2023 slump, fueled by census and growth. Transaction volume declined in the hospice and home-based care space in 2023, following the two record-breaking prior years. Many expect a rebound in 2024, and stirrings in the public company space signal that may come […]

Addus HomeCare to Accelerate Acquisition Activity

Though the acquisition market has slowed down this year for home-based care companies, Addus HomeCare Corp. (NASDAQ: ADUS) remains on the hunt. The most prominent home-based care transactions so far this year have involved payers seeking to acquire large providers with multiple business lines. Addus has been among the few publicly traded companies that have […]

3 Palliative Care Providers to Watch

As the demand for palliative care continues to grow, so too has the way businesses have bolstered their programs to better serve patients. Providers are consistently looking for new methods to deliver responsive, value-based services that can generate savings and reduce high-acuity utilization. Hospice News spoke with three palliative care providers that have risen to […]

Hospice Length of Stay: Balancing Patient Needs Against Regulatory Compliance

Though evidence shows that longer hospice stays reduce costs, providers are still walking a regulatory tightrope. On one hand, longer hospice stays can lead to improved patient and family satisfaction and greater cost saving opportunities. On the other hand, regulators often treat stays longer than six months or frequent recertifications to be red flags that […]

Hospice Providers Weigh Labor Gains Against Rising Costs

When it comes to labor, hospice providers are walking a balance beam between the need to increase capacity and the long-term sustainability of offering bonuses, tech investments and larger benefits packages. Publicly traded hospice providers have reported improvements on turnover and  workforce shortages. But the strides have come at a cost. While the public companies […]

What Gentiva’s Expanded Hospice Presence Means for the M&A Mix

Gentiva’s recent $710 million acquisition of ProMedica’s hospice and home-based care assets bucks prevailing trends in today’s M&A market. Transaction volume dipped during 2022, specifically when it came to large platform deals by private equity firms. Many in the space expect smaller deals to become more prevalent during the first half of 2023, particularly in […]

Addus Expects ‘Bit of Bumpiness’ in Hospice, Looks to Further Grow Home Health Business

Staffing improvements and reimbursement shifts are paving Addus HomeCare’s (NASDAQ: ADUS) growth path this year. That path will divert more toward home health and personal care – and less in the direction of hospice – as 2023 progresses. Addus’ more than 33,000 employees serve around 46,500 patients across roughly 200 locations nationwide. The company added […]

Queen City Hospice Expands in Rural Ohio with New Office

Ohio-based Queen City Hospice, an Addus Homecare (NASDAQ: ADUS) company, recently opened a new location in its home state. The new location in Fayetteville, Ohio, adds a central office in a rural region of the hospice’s service area that will reduce staff travel time. Queen City Hospice provides end-of-life care in six counties across the […]

Hospice M&A Going Strong, But Non-Medical Home Care a Rising Star

While hospice and home health M&A continue to burgeon, non-medical home care is starting to slip out from under their shadows. Deal volume for non-medical home care companies outstripped that for hospice or home health during the first half of the year. As of the end of Q2, this included 23 deals compared to 17 […]

Publicly Traded Hospice Execs See Signs of Improvement in Labor Market

Some hospice company leaders have signaled the labor market may be showing signs of stabilization. Executives from 13 publicly traded home-based care companies participated last week in Jeffries Financial Group’s annual Nashville Healthcare Services Burr Tour, including contingents from Addus (NASDAQ: ADUS), Amedisys (NASDAQ: AMED), CVS Health (NASDAQ: CVS), Signify Health (NASDAQ: SGNY), and Enhabit […]